Cargando…

Case Report: Dynamics of Acquired Fluoroquinolone Resistance under Standardized Short-Course Treatment of Multidrug-Resistant Tuberculosis

We report a case of acquired fluoroquinolone (FQ) resistance under short-course multidrug-resistant tuberculosis (MDR-TB) treatment. The patient was managed at Kabutare hospital, one of the two specialized MDR-TB clinics in Rwanda. A low dose of moxifloxacin was used in the first three critical mont...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ngabonziza, Jean Claude Semuto, Van Deun, Armand, Migambi, Patrick, Niyigena, Esdras Belamo, Dusabe, Théogène, Habimana, Yves Mucyo, Ushizimpumu, Bertin, Mulders, Wim, Decroo, Tom, Affolabi, Dissou, Supply, Philip, de Jong, Bouke C., Rigouts, Leen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The American Society of Tropical Medicine and Hygiene 2020
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7543851/ https://www.ncbi.nlm.nih.gov/pubmed/32618257 http://dx.doi.org/10.4269/ajtmh.20-0201

Ejemplares similares

Continuous surveillance of drug-resistant TB burden in Rwanda: a retrospective cross-sectional study
por: Habimana-Mucyo, Yves, et al.
Publicado: (2022)

Multidrug-resistant tuberculosis control in Rwanda overcomes a successful clone that causes most disease over a quarter century
por: Ngabonziza, Jean Claude S., et al.
Publicado: (2022)

A sister lineage of the Mycobacterium tuberculosis complex discovered in the African Great Lakes region
por: Ngabonziza, Jean Claude Semuto, et al.
Publicado: (2020)

Predictors of Rifampicin-Resistant Tuberculosis Mortality among HIV-Coinfected Patients in Rwanda
por: Habimana, Dominique Savio, et al.
Publicado: (2021)

Low Cycle Threshold Value in Xpert MTB/RIF Assay May Herald False Detection of Tuberculosis and Rifampicin Resistance: A Study of Two Cases
por: Ngabonziza, Jean Claude S, et al.
Publicado: (2021)

Bedaquiline can act as core drug in a standardised treatment regimen for fluoroquinolone-resistant rifampicin-resistant tuberculosis
por: Decroo, Tom, et al.
Publicado: (2022)

Correlation of different phenotypic drug susceptibility testing methods for four fluoroquinolones in Mycobacterium tuberculosis
por: Coeck, Nele, et al.
Publicado: (2016)

Initial resistance to companion drugs should not be considered an exclusion criterion for the shorter multidrug-resistant tuberculosis treatment regimen
por: Lempens, Pauline, et al.
Publicado: (2020)

Half of rifampicin-resistant Mycobacterium tuberculosis complex isolated from tuberculosis patients in Sub-Saharan Africa have concomitant resistance to pyrazinamide
por: Ngabonziza, Jean Claude Semuto, et al.
Publicado: (2017)

Genotypic characterization directly applied to sputum improves the detection of Mycobacterium africanum West African 1, under-represented in positive cultures
por: Sanoussi, C. N’Dira, et al.
Publicado: (2017)

Acquired rifampicin resistance during first TB treatment: magnitude, relative importance, risk factors and keys to control in low-income settings
por: Van Deun, Armand, et al.
Publicado: (2022)

Variable ability of rapid tests to detect Mycobacterium tuberculosis rpoB mutations conferring phenotypically occult rifampicin resistance
por: Torrea, Gabriela, et al.
Publicado: (2019)

Isoniazid resistance levels of Mycobacterium tuberculosis can largely be predicted by high-confidence resistance-conferring mutations
por: Lempens, Pauline, et al.
Publicado: (2018)

Storage of Sputum in Cetylpyridinium Chloride, OMNIgene.SPUTUM, and Ethanol Is Compatible with Molecular Tuberculosis Diagnostic Testing
por: Sanoussi, C. N’Dira, et al.
Publicado: (2019)

Possible Outbreak of Streptomycin-Resistant Mycobacterium tuberculosis Beijing in Benin
por: Affolabi, Dissou, et al.
Publicado: (2009)

Spot specimen testing with GeneXpert MTB/RIF results compared to morning specimen in a programmatic setting in Cotonou, Benin
por: Massou, Faridath, et al.
Publicado: (2021)

Should treatment of low-level rifampicin mono-resistant tuberculosis be different?
por: Van Deun, Armand, et al.
Publicado: (2021)

Xpert Ultra Can Unambiguously Identify Specific Rifampin Resistance-Conferring Mutations
por: Ng, Kamela C. S., et al.
Publicado: (2018)

Definitive outcomes in patients with rifampicin-resistant tuberculosis treated in Niger from 2012 to 2019: A retrospective cohort study
por: Souleymane, Mahamadou Bassirou, et al.
Publicado: (2022)

Borderline rpoB mutations transmit at the same rate as common rpoB mutations in a tuberculosis cohort in Bangladesh
por: Lempens, Pauline, et al.
Publicado: (2023)

GeneXpert MTB/RIF Ultra performance to detect uncommon rpoB mutations in Mycobacterium tuberculosis
por: Rigouts, Leen, et al.
Publicado: (2023)

Acquired bedaquiline resistance during the treatment of drug-resistant tuberculosis: a systematic review
por: Mallick, Jahan Saeed, et al.
Publicado: (2022)

False Rifampicin Resistance in Xpert Ultra Applied to Lymph Node Aspirate: A Case Report
por: Ng, Kamela C S, et al.
Publicado: (2020)

The perceived impact of isoniazid resistance on outcome of first-line rifampicin-throughout regimens is largely due to missed rifampicin resistance
por: Van Deun, Armand, et al.
Publicado: (2020)

Injectables’ key role in rifampicin-resistant tuberculosis shorter treatment regimen outcomes
por: Decroo, Tom, et al.
Publicado: (2020)

Shifts in Mycobacterial Populations and Emerging Drug-Resistance in West and Central Africa
por: Gehre, Florian, et al.
Publicado: (2014)

High-Dose First-Line Treatment Regimen for Recurrent Rifampicin-Susceptible Tuberculosis
por: Decroo, Tom, et al.
Publicado: (2020)

How Well Do Routine Molecular Diagnostics Detect Rifampin Heteroresistance in Mycobacterium tuberculosis?
por: Ng, Kamela C. S., et al.
Publicado: (2019)

Short-Course Regimen for Multidrug-Resistant Tuberculosis: A Decade of Evidence
por: Trébucq, Arnaud, et al.
Publicado: (2019)

Mycobacterium tuberculosis complex lineage 5 exhibits high levels of within-lineage genomic diversity and differing gene content compared to the type strain H37Rv
por: Sanoussi, C. N'Dira, et al.
Publicado: (2021)

Unexpected high prevalence of resistance-associated Rv0678 variants in MDR-TB patients without documented prior use of clofazimine or bedaquiline
por: Villellas, Cristina, et al.
Publicado: (2017)

Factors Influencing Fluoroquinolone Resistance
por: Sahm, Daniel F., et al.
Publicado: (2003)

Fluoroquinolone resistance in Neisseria gonorrhoeae.
por: Knapp, J S, et al.
Publicado: (1997)

Fluoroquinolone-resistant Streptococcus pneumoniae
por: Pletz, Mathias W.R., et al.
Publicado: (2006)

Emerging mechanisms of fluoroquinolone resistance.
por: Hooper, D C
Publicado: (2001)

Trends in fluoroquinolone resistance in Campylobacter
por: Sproston, Emma L., et al.
Publicado: (2018)

Fluoroquinolone resistance in multidrug-resistant tuberculosis patients
por: Lee, Hyun-Woo, et al.
Publicado: (2019)

Diagnostic Bacteriology in District Hospitals in Sub-Saharan Africa: At the Forefront of the Containment of Antimicrobial Resistance
por: Jacobs, Jan, et al.
Publicado: (2019)

Community-supported self-administered tuberculosis treatment combined with active tuberculosis screening: a pilot experience in Conakry, Guinea
por: Hassane-Harouna, Souleymane, et al.
Publicado: (2023)

Potential Application of Digitally Linked Tuberculosis Diagnostics for Real-Time Surveillance of Drug-Resistant Tuberculosis Transmission: Validation and Analysis of Test Results
por: Ng, Kamela Charmaine, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_6r4pt39690errn10pmpcma58s5